RESQ PHARMA, INC.

Profile

Company Names

RESQ PHARMA, INC.

Addresses

2516 WAUKEGAN ROAD, SUITE 375, GLENVIEW, IL 60025

2242 W. HARRISON ST., #201, CHICAGO, IL 60612

Phone Numbers

312-719-7702
224-880-6001

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$2,390,000.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2024-07-27 
$99,999.00 
$100,000.00 
$1.00 
Equity 
4
2022-05-13 
$205,501.00 
$300,000.00 
$94,499.00 
Equity 
3
2020-06-22 
$1,020,000.00 
$2,000,000.00 
$980,000.00 
Equity 
2
2016-08-31 
$739,500.00 
$764,500.00 
$25,000.00 
Equity 
1
2015-09-17 
$325,000.00 
$325,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
TODD 
 
BECK 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
QUICKET SOLUTIONS, INC.   |  RESQ PHARMA, INC.
DAVID 
 
BOWMAN 
EXECUTIVE OFFICER
WELLAWARE SYSTEMS, INC.   |  PERSONAL WEB SYSTEMS, INC.   |  SVIRAL, INC.   |  RESQ PHARMA, INC.   |  RINGIT, INC.   |  MISSION BARNS, INC.   |  G+B HOLDCO, INC.   |  SATURDAY LANDSCAPES LLC
PAUL 
 
BURTON 
EXECUTIVE OFFICER, DIRECTOR
VIVACELLE BIO, INC.   |  RESQ PHARMA, INC.   |  LENDINGCOIN, INC.   |  SPECIAL PROJECT, INC.   |  CANCER IQ INC.   |  BRIDGETOWER CAPITAL, INC.   |  CARDIO DIAGNOSTICS HOLDINGS, INC.
STEVE 
 
BYLINA 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
RESQ PHARMA, INC.
ANTOINETTE 
 
GAWIN 
DIRECTOR, EXECUTIVE OFFICER, PROMOTER
RESQ PHARMA, INC.
PAUL 
 
HERTZ 
DIRECTOR, EXECUTIVE OFFICER, PROMOTER
RESQ PHARMA, INC.
DOMINIC 
 
O-KEEFE 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
RESQ PHARMA, INC.
ISRAEL 
 
RUBINSTEIN 
DIRECTOR
RESQ PHARMA, INC.
AUGUST 
H. 
SCHUPP 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
RESQ PHARMA, INC.
JOEL 
 
TUNE 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
UNIGENE LABORATORIES INC   |  RESQ PHARMA, INC.
GUY 
 
WEINBERG 
DIRECTOR, EXECUTIVE OFFICER, PROMOTER
RESQ PHARMA, INC.
FRANCIS 
 
WISNIEWSKI 
DIRECTOR, EXECUTIVE OFFICER, PROMOTER
HARD EIGHT MULTI-STRATEGY FUND LLC   |  FORTY4 FUND LLC   |  FORTY4 FUND LTD.   |  FORTY4 INSTITUTIONAL FUND LLC   |  RESQ PHARMA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-12-31
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-27 
2022-06-16
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-05-13 
2020-09-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-06-22 
2016-09-16
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-08-31 
2016-03-02
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#